NCT02688049 - NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Spinal Cord Injury

Interventions

BIOLOGICAL

NeuroRegen scaffold/mesenchymal stem cells transplantation

Patients with chronic SCI (ASIA grade A) will receive NeuroRegen Scaffold with 10 million mesenchymal stem cells transplantation after localized scars cleared and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures.

BIOLOGICAL

NeuroRegen scaffold/neural stem cells transplantation

Patients with chronic SCI (ASIA grade A) will receive NeuroRegen Scaffold with 10 million neural stem cells transplantation after localized scars cleared and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures.

Trial Locations (1)

300162

Affiliated Hospital of Logistics Universtiy of CAPF, Tianjin